We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
BTG | LSE:BGC | London | Ordinary Share | GB0001001592 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 387.50 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
30/1/2012 10:47 | Neil Woodford must be happy. We might even start getting dividends in 2013. | waterloo01 | |
30/1/2012 10:43 | Good, they'll soon be getting those slide rulers out again once this gets over £4.00 & FTSE entry waiting when all those trackers funds will have to buy stock. Whoopy doop. | bobby.ifa | |
30/1/2012 10:36 | I see that Daniel Stewart have upped their target from 337 to 375p | wywcu1 | |
30/1/2012 10:11 | Dips? Just buy while it's under £5.00 | waterloo01 | |
30/1/2012 10:03 | waterloo fully agree and that is why i invested buy on dips as these are going much higher with time and yes they get 100% of the profit on varisolve. you must note traditional vv stripping has higher costs and higher complications and less profit to surgeon than foam injection | doctor 69 | |
30/1/2012 10:00 | Varisolve could easily be worth $500m a year to BTG. It has the potential to replace surgury in 80% of cases. Add in the number of cases that people 'live' with because of the risks of surgury and it could be even higher. In other words it could triple the turnover of BTG and with 100% ownwership it will be transformative on profit | waterloo01 | |
30/1/2012 09:23 | Excellent announcement; seeing phrases from doctors such as this, "If Varisolve(R) demonstrates the same sort of significant improvement in symptoms and acceptable safety profile in the additional Phase III trials, it should provide an important new treatment option for varicose veins. It has been a great trial to be part of as my patients have been so happy with their results" is very encouraging. This result, and further successful III results WILL propel the share price Hold on to your hats ! | thekobbler | |
30/1/2012 08:46 | Oh no, retrace commencing! | bobby.ifa | |
30/1/2012 08:44 | Bloody hell. Varisolve finally...surely not. It's been the gold at the end of the rainbow and BTG downfall for ever. Excellent and they have 100% of it. | waterloo01 | |
30/1/2012 08:39 | Potential market is huge, at present only a relatively small proportion of patients get veins treated, and the incidence will increase with an ageing population anyway. The most significant result here is the absence of adverse events, which is at least as important as efficacy. Still plenty of hurdles to jump though. DYOR. | bonzo | |
30/1/2012 08:14 | the p values on this trial are massively stastical and this will impress doctors thinking of using it. this is no minor effect , this is stunning. BTG have been pretty quiet about vv recently but this is massive for them and i would expect analysts to focus more on this. | doctor 69 | |
30/1/2012 08:13 | Wow, what a welcome tick up! Great news should see this breaking thuse Broker forecasts now. What is the potential Income like on this product? | bobby.ifa | |
30/1/2012 08:09 | What a great start to the week! In today's Torygraph, this is the first 'happy day of the year' -they got that right! | fhmktg | |
30/1/2012 07:30 | Nice one! Good luck all 'long termers' here. | bodgit | |
30/1/2012 07:24 | Looking forward to the next phase of a very exciting ride achieving progressively higher highs in coming weeks, months and years..... Good luck to all fellow investors. | moretimeforlife | |
30/1/2012 07:14 | Looking good | wywcu1 | |
26/1/2012 18:43 | I think the foam works out cheaper for patient , safer and more lucrative for surgeon than stripping vv | doctor 69 | |
26/1/2012 16:04 | I always understood that home brews only for minor veins problems also that not available on NHS due to impossible to get insurance cover ie if you want it, have it private and take a chance on the cover aspect. Ssords | ssords | |
26/1/2012 15:16 | I would think that in due course we will get a RNS, specific or with other info, to the effect that all the data has been submitted to FDA. | alanrussell | |
26/1/2012 14:36 | Varisolve Data analysis underway - from interim statement. Given that the trials were completed seven weeks early can we hope for announcement early? Any views as to whether the Company will announce trial by trial or wait for the full set? | fhmktg | |
25/1/2012 12:57 | Should spike on the Dow opening today. | bargainbob | |
25/1/2012 12:55 | spot on lingy - it's started. | wywcu1 | |
25/1/2012 10:43 | TRUE WILL BREAK SOON IMO | lingy | |
25/1/2012 10:41 | AT traders looking to keep a cap on any upward momentum - pretty tedious and predictable! | fhmktg | |
25/1/2012 08:00 | Looks are very straight forward confident update.IMHO | bargainbob |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions